Bargains! PROMOTIONS

Close Notification

Your cart does not contain any items

CRISPR-Cas9 Technology for Precision Medicine

Jen-Tsung Chen

$479.95   $383.76

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Medical Information Science Reference
07 January 2026
CRISPR-Cas9 technology emerges as one of the most powerful tools in modern biomedical science, offering precision in genetic and genomic editing. By enabling targeted modifications to DNA with accuracy, CRISPR-Cas9 unveils a new era of precision medicine in which treatments are tailored to the genetic makeup of individual patients. This technology corrects disease-causing mutations, engineers patient-specific therapies, and creates safer, more effective interventions across a wide range of genetic and complex diseases. As research advances, CRISPR-Cas9 continues to redefine applications in personalized healthcare. CRISPR-Cas9 Technology for Precision Medicine explores how CRISPR-Cas9 enables highly targeted and efficient genome editing to support personalized approaches to disease prevention, diagnosis, and treatment. It examines the potential of technology to correct genetic mutations, develop individualized therapies, and transform precision medicine. This book covers topics such as medical therapeutics, oncology, and genetic editing, and is a useful resource for medical and healthcare professionals, geneticists, academicians, researchers, and scientists.
Edited by:  
Imprint:   Medical Information Science Reference
Country of Publication:   United States
Dimensions:   Height: 254mm,  Width: 178mm, 
ISBN:   9798337348582
Pages:   488
Publication Date:  
Audience:   College/higher education ,  Professional and scholarly ,  Primary ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Dr. Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen’s research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and international journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, materials science, ethnopharmacology, and systems biology. He serves as an associate editor, editorial board member, and guest editor in reputed journals. Dr. Chen published books in collaboration with international publishers, and he is handling book projects on diverse topics such as AI technologies, drug discovery, drug development, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, epigenetics, functional RNAs, and CRISPR-based genome editing. Dr. Chen is a productive author in academic publications and was recognized as one of the World's Top 2% Scientists 2023, 2024, and 2025 by Elsevier and Stanford University. Dr. Chen received the Springer Nature Editor of Distinction Award in 2025.

See Also